NCT02343601 2026-04-02
PANEX3
University Hospital, Caen
Phase 3 Completed
Clinical Trials
13 trialsNCT05040464 2025-05-28
COMET
Centre Hospitalier Universitaire, Amiens
Phase 3 Recruiting
NCT04712032 2021-01-15
AVOID
Leiden University Medical Center
Phase 3 Unknown
NCT02499783 2019-01-04
Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease
AbbVie
Phase 3 Completed
NCT00552058 2018-08-09
Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
UCB Pharma
Phase 3 Completed
NCT00333788 2018-08-07
Welcome2
UCB Pharma
Phase 3 Completed
NCT01369329 2016-12-07
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
Janssen Research & Development, LLC
Phase 3 Completed
NCT00004941 2015-03-25
Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease
FDA Office of Orphan Products Development
Phase 3 Completed
NCT00354367 2012-05-28
Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas
UCB Pharma
Phase 3 Withdrawn
NCT00358683 2012-05-28
A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease
UCB Pharma
Phase 3 Withdrawn
NCT00297648 2011-08-31
MUSIC
UCB Pharma
Phase 3 Completed
NCT00467922 2009-10-21
An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy
Corewell Health West
Phase 3 Completed
NCT00290524 2006-04-07
Early Alimentation Following Colorectal Surgery
Maisonneuve-Rosemont Hospital
Phase 3 Unknown